Quality operations is an essential function of the life sciences industry and Switzerland’s pharmaceutical industry is supported by its global reputation for high-quality production standards. Drug manufacturers must thoroughly test materials, processes, equipment, techniques, environments and personnel in order to ensure their final products are consistent, safe, effective and predictable. Of the medicines that are tested on people, 90% don’t reach the market because they are unsafe or ineffective.
A new phase in the industrial revolution has the potential to revolutionise the quality process. Industry 4.0. is ushering in a new era of interdisciplinary research and practice that focuses heavily on interconnectivity, automation, machine learning, and real-time data. According to a report by Pharma Manufacturing, the first real-life cases of implementing such innovations have delivered a 50% reduction in overall quality control costs. In Deloitte’s Global Life Sciences Sector Outlook, research points to “an evolving regulatory and risk environment” heightening the need for skilled life sciences professionals. As the life sciences industry continues to grow, so too will the medical device and pharmaceutical quality assurance sectors.
Given the extensive size of the life sciences industry in Switzerland, there are multiple established associations with expansive networks for professionals in the industry to gain membership to such as Swiss Professional Association of Quality Assurance and the Society of Quality Assurance. In Switzerland, Swissmedic is the national authorisation and supervisory authority for drugs and medical products. The agency ensures that only high-quality, safe and effective medical products are available in Switzerland.
Our Zurich based consultants are specialists in their markets, recruiting top talent for the quality jobs market throughout Switzerland and Europe.